ClinicalTrials.gov
ClinicalTrials.gov Menu

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00405171
Recruitment Status : Completed
First Posted : November 29, 2006
Last Update Posted : October 28, 2010
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by:
University Hospital, Caen